391 related articles for article (PubMed ID: 18754805)
1. The effect of cholecalciferol supplementation on vitamin D levels and insulin sensitivity is dose related in vitamin D-deficient HIV-1-infected patients.
van den Bout-van den Beukel CJ; van den Bos M; Oyen WJ; Hermus AR; Sweep FC; Tack CJ; Bosch ME; Burger DM; Koopmans PP; van der Ven AJ
HIV Med; 2008 Oct; 9(9):771-9. PubMed ID: 18754805
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Percent true calcium absorption, mineral metabolism, and bone mass in children with arthritis: effect of supplementation with vitamin D3 and calcium.
Hillman LS; Cassidy JT; Chanetsa F; Hewett JE; Higgins BJ; Robertson JD
Arthritis Rheum; 2008 Oct; 58(10):3255-63. PubMed ID: 18821668
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis.
Hiremath GS; Cettomai D; Baynes M; Ratchford JN; Newsome S; Harrison D; Kerr D; Greenberg BM; Calabresi PA
Mult Scler; 2009 Jun; 15(6):735-40. PubMed ID: 19383644
[TBL] [Abstract][Full Text] [Related]
5. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency.
Leventis P; Kiely PD
Scand J Rheumatol; 2009; 38(2):149-53. PubMed ID: 18991184
[TBL] [Abstract][Full Text] [Related]
6. Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation.
Jean G; Souberbielle JC; Chazot C
Nephrol Dial Transplant; 2009 Dec; 24(12):3799-805. PubMed ID: 19622574
[TBL] [Abstract][Full Text] [Related]
7. The effect of low-dose cholecalciferol and calcium treatment on posttransplant bone loss in renal transplant patients: a prospective study.
Sahin G; Yasar NS; Sirmagul B; Bal C; Yalcin AU
Ren Fail; 2008; 30(10):992-9. PubMed ID: 19016151
[TBL] [Abstract][Full Text] [Related]
8. Elevated PTH levels in hypovitaminosis D are more rapidly suppressed by the administration of 1,25-dihydroxy-vitamin D3 than by vitamin D3.
Theiler R; Bischoff H; Tyndall A; Stähelin HB
Int J Vitam Nutr Res; 1998; 68(1):36-41. PubMed ID: 9503046
[TBL] [Abstract][Full Text] [Related]
9. Effects of long-term cholecalciferol supplementation on mineral metabolism and calciotropic hormones in chronic kidney disease.
Oksa A; Spustová V; Krivosíková Z; Gazdíková K; Fedelesová V; Lajdová I; Stefíková K; Bernasovská G; Zilinská Z; Dzúrik R
Kidney Blood Press Res; 2008; 31(5):322-9. PubMed ID: 18802363
[TBL] [Abstract][Full Text] [Related]
10. Cholecalciferol supplementation in chronic kidney disease: restoration of vitamin D status and impact on parathyroid hormone.
Garcia-Lopes MG; Pillar R; Kamimura MA; Rocha LA; Canziani ME; Carvalho AB; Cuppari L
Ann Nutr Metab; 2012; 61(1):74-82. PubMed ID: 22889840
[TBL] [Abstract][Full Text] [Related]
11. High-dose vitamin D3 supplementation is a requisite for modulation of skin-homing markers on regulatory T cells in HIV-infected patients.
Khoo AL; Koenen HJ; Michels M; Ooms S; Bosch M; Netea MG; Joosten I; van der Ven AJ
AIDS Res Hum Retroviruses; 2013 Feb; 29(2):299-306. PubMed ID: 22720723
[TBL] [Abstract][Full Text] [Related]
12. Body fat and cholecalciferol supplementation in elderly homebound individuals.
Canto-Costa MH; Kunii I; Hauache OM
Braz J Med Biol Res; 2006 Jan; 39(1):91-8. PubMed ID: 16400469
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D, osteoprotegerin/receptor activator of nuclear factor-kappaB ligand (OPG/RANKL) and inflammation with alendronate treatment in HIV-infected patients with reduced bone mineral density.
Natsag J; Kendall MA; Sellmeyer DE; McComsey GA; Brown TT
HIV Med; 2016 Mar; 17(3):196-205. PubMed ID: 26177791
[TBL] [Abstract][Full Text] [Related]
14. Bone mass preservation with high-dose cholecalciferol and dietary calcium in HIV patients following antiretroviral therapy. Is it possible?
Mela Q; Ruggiero V; Montaldo L; Pisano U; Matta L; Maria Pasetto C; Onali S; Cacace E; Carta MG; Barca L; Chessa L
HIV Clin Trials; 2018 Oct; 19(5):188-196. PubMed ID: 30445888
[TBL] [Abstract][Full Text] [Related]
15. High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients.
Tokmak F; Quack I; Schieren G; Sellin L; Rattensperger D; Holland-Letz T; Weiner SM; Rump LC
Nephrol Dial Transplant; 2008 Dec; 23(12):4016-20. PubMed ID: 18593741
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D deficiency, insulin resistance, serum adipokine, and leptin levels in peritoneal dialysis patients.
Ulutas O; Taskapan H; Taskapan MC; Temel I
Int Urol Nephrol; 2013 Jun; 45(3):879-84. PubMed ID: 23065434
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men.
Nagpal J; Pande JN; Bhartia A
Diabet Med; 2009 Jan; 26(1):19-27. PubMed ID: 19125756
[TBL] [Abstract][Full Text] [Related]
18. Bone turnover and maternal 25(OH) vitamin D3 levels during pregnancy and the postpartum period: should routine vitamin D supplementation be increased in pregnant women?
Haliloglu B; Ilter E; Aksungar FB; Celik A; Coksuer H; Gunduz T; Yucel E; Ozekici U
Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):24-7. PubMed ID: 21543150
[TBL] [Abstract][Full Text] [Related]
19. Alendronate/vitamin D3 70 mg/2800 IU with and without additional 2800 IU vitamin D3 for osteoporosis: results from the 24-week extension of a 15-week randomized, controlled trial.
Binkley N; Ringe JD; Reed JI; Ljunggren O; Holick MF; Minne HW; Liu M; Lamotta A; West JA; Santora AC
Bone; 2009 Apr; 44(4):639-47. PubMed ID: 19185560
[TBL] [Abstract][Full Text] [Related]
20. Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects.
Beilfuss J; Berg V; Sneve M; Jorde R; Kamycheva E
Cytokine; 2012 Dec; 60(3):870-4. PubMed ID: 22925537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
